Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bioadaptives (BDPT) Inventory (2016 - 2025)

Bioadaptives' Inventory history spans 8 years, with the latest figure at $44706.0 for Q4 2025.

  • On a quarterly basis, Inventory rose 133.88% to $44706.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $44706.0, a 133.88% increase, with the full-year FY2025 number at $44706.0, up 133.88% from a year prior.
  • Inventory hit $44706.0 in Q4 2025 for Bioadaptives, up from $44228.0 in the prior quarter.
  • Over the last five years, Inventory for BDPT hit a ceiling of $44706.0 in Q4 2025 and a floor of $3572.0 in Q1 2022.
  • Historically, Inventory has averaged $16577.5 across 5 years, with a median of $10647.0 in 2022.
  • Biggest five-year swings in Inventory: plummeted 70.93% in 2022 and later surged 559.57% in 2025.
  • Tracing BDPT's Inventory over 5 years: stood at $4750.0 in 2021, then soared by 86.88% to $8877.0 in 2022, then surged by 72.14% to $15281.0 in 2023, then rose by 25.09% to $19115.0 in 2024, then soared by 133.88% to $44706.0 in 2025.
  • Business Quant data shows Inventory for BDPT at $44706.0 in Q4 2025, $44228.0 in Q3 2025, and $39574.0 in Q2 2025.